AVE Science & Technology Co

AVE Science & Technology Co Total Assets

The Total Assets of AVE Science & Technology Co (688067.SS) as of Oct 21, 2026 is 580.12 M CNY. In the previous year, Total Assets was 561.00 M CNY — a change of 3.41% (higher).

Total Assets

580.12 MCNY

YoY

3.41%

Last updated:

Total Assets of AVE Science & Technology Co is 2025 580.12 M CNY. Total Assets of AVE Science & Technology Co was 2024 561.00 M CNY. It decreases by 3.41% higher compared to the previous year.

The AVE Science & Technology Co Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2018
257.67 M CNY
Jan 1, 2019
297.44 M CNY
Jan 1, 2020
296.57 M CNY
Jan 1, 2021
547.61 M CNY
Jan 1, 2022
549.65 M CNY
Jan 1, 2023
556.69 M CNY
Jan 1, 2024
561.00 M CNY
Jan 1, 2025
580.12 M CNY
The AVE Science & Technology Co Total Assets history
YEARTotal AssetsYoY
580.12 MCNY+3.41%
561.00 MCNY+0.77%
556.69 MCNY+1.28%
549.65 MCNY+0.37%
547.61 MCNY+84.65%
296.57 MCNY-0.29%
297.44 MCNY+15.44%
257.67 MCNY+14.99%
224.08 MCNY+6.01%
211.37 MCNY+26.93%
166.53 MCNY+3.48%
160.93 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AVE Science & Technology Co Stock analysis

What does AVE Science & Technology Co do? AVE Science & Technology Co., Ltd. generates revenue through the research, development, production, sale, and service of clinical testing and analysis instruments. Its main products include urine formed component analyzer, urine dry chemistry analyzer, urine full item automatic analyzer, automatic stool analyzer, automatic body fluid analyzer, reproductive tract secretion analyzer, and special supporting in vitro diagnostic reagents and medical consumables. These products are primarily sold to inspection departments within medical and health institutions in both domestic and overseas markets. The company serves healthcare facilities that require diagnostic equipment for laboratory testing and patient care. The firm's product portfolio targets healthcare institutions seeking advanced diagnostic tools for efficient clinical analysis. By focusing on specialized instruments like urine and stool analyzers, AVE Science & Technology addresses specific needs in medical testing departments. The company's domestic and international distribution channels ensure broad market access for its diagnostic solutions. AVE Science & Technology's revenue streams are derived from the sale of its comprehensive range of clinical testing instruments and related consumables. The company's domestic market presence and overseas sales contribute to its overall business performance. Its products support routine diagnostic procedures across various healthcare settings, driving consistent demand for its equipment and reagents. AVE Science & Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AVE Science & Technology Co stock

Total Assets of AVE Science & Technology Co is 580.12 M CNY in 2025.

Total Assets of AVE Science & Technology Co changed from 561.00 M CNY to 580.12 M CNY, representing a 3.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets AVE Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's AVE Science & Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — AVE Science & Technology Co

All Key Metrics — AVE Science & Technology Co